Lawton Vincent Michaelinsider trades
In SEC Form 4 filings, Lawton Vincent Michael is listed as Director of Addex Therapeutics Ltd. (ADXN). Lawton Vincent Michael reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 4.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ADXNAddex Therapeutics Ltd. | Director | 4 | Sep 4 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-04
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D | 2,507,487 | $0.00 | $0 | 500 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A | 2,507,487 | $0.00 | $0 | 2,507,987 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 501,598 | $0.06 | $31,099 | not reported | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 501,598 | $0.03 | $16,051 | 501,598 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.